Home » Stocks » EBS

Emergent BioSolutions, Inc. (EBS)

Stock Price: $63.51 USD -1.97 (-3.01%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
After-hours: $64.00 +0.49 (0.77%) Jun 11, 7:54 PM
Market Cap 3.40B
Revenue (ttm) 1.71B
Net Income (ttm) 387.30M
Shares Out 53.30M
EPS (ttm) 7.12
PE Ratio 8.92
Forward PE 8.38
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $63.51
Previous Close $65.48
Change ($) -1.97
Change (%) -3.01%
Day's Open 65.51
Day's Range 62.72 - 66.12
Day's Volume 829,603
52-Week Range 55.07 - 137.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investor...

1 day ago - Newsfile Corp

GAITHERSBURG, Md., June 11, 2021 (GLOBE NEWSWIRE) --  Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batches of COVID-19 vaccine manufactured by Emergent BioSolutions at its Baltimore Ba...

2 days ago - GlobeNewsWire

New Orleans, Louisiana--(Newsfile Corp. - June 10, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unt...

3 days ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - June 10, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") that Kessler Topaz Me...

3 days ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - June 9, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Emergent BioSolutions Inc. (NYSE: EBS...

4 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - June 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emerg...

4 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - June 8, 2021) -  The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Emergent Biosolutions Inc. (NYSE:...

5 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - June 8, 2021) -  The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Emergent Biosolution...

5 days ago - Newsfile Corp

RADNOR, Pa., June 8, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action against Emergent BioSolutions Inc. (NYSE: E...

5 days ago - PRNewsWire

New York, New York--(Newsfile Corp. - June 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) allegi...

5 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - June 5, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors...

1 week ago - Newsfile Corp

NEW YORK, June 4, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24, 2020 throu...

1 week ago - PRNewsWire

Radnor, Pennsylvania--(Newsfile Corp. - June 4, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") that Kessler Topaz Mel...

1 week ago - Newsfile Corp

New Orleans, Louisiana--(Newsfile Corp. - June 3, 2021) -  Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unt...

1 week ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)--Entwistle & Cappucci LLP Announces It Has Filed a Securities Class Action Against Emergent BioSolutions Inc.

1 week ago - Business Wire

San Francisco, California--(Newsfile Corp. - June 3, 2021) -  Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr....

1 week ago - Newsfile Corp

RADNOR, Pa., June 2, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") investors that the firm has filed a securities fr...

1 week ago - PRNewsWire

NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to...

1 week ago - PRNewsWire

Radnor, Pennsylvania--(Newsfile Corp. - May 31, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action aga...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 29, 2021) - WHY:. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between Apri...

2 weeks ago - Newsfile Corp

RADNOR, Pa., May 28, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Emergent ...

2 weeks ago - PRNewsWire

The FDA and Johnson & Johnson (NYSE: JNJ) are expected to announce that contamination problems at Emergent BioSolutions Inc's (NYSE: EBS) Baltimore Bayview plant have been resolved, and production is se...

Other stocks mentioned: JNJ
2 weeks ago - Benzinga

New Orleans, Louisiana--(Newsfile Corp. - May 28, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unti...

2 weeks ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 27, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action against Emergent BioSolutions...

2 weeks ago - Newsfile Corp

Emergent BioSolutions Inc (NYSE: EBS) has announced two-year persistence data from its Phase 2 study evaluating its investigational chikungunya virus, virus-like particle (CHIKV VLP) vaccine candidate. ...

2 weeks ago - Benzinga

GAITHERSBURG, Md., May 26, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced two-year persistence data from its Phase 2 clinical study evaluating the safety and immunogenicity of ...

2 weeks ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - May 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) allegi...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 25, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders Emergent Biosolutions Inc. (NYSE: EBS)...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 25, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Emergent Biosolutions Inc.Sharehol...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 25, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Emergent Biosolutions...

2 weeks ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - May 24, 2021) -  Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr....

2 weeks ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 24, 2021) -  The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action ag...

2 weeks ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - May 23, 2021) - Berger Montague announces its investigation into securities fraud allegations against Emergent BioSolutions Inc. ("Emergent" or the "Company...

3 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 22, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investor...

3 weeks ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2021) - Berger Montague is investigating securities fraud allegations against Emergent BioSolutions Inc. ("Emergent" or the "Company") on behalf of ...

3 weeks ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Berger Montague is investigating potential securities fraud claims against Emergent BioSolutions Inc. ("Emergent" or the "Company") on behal...

3 weeks ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 21, 2021) -  The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action against Emergent BioSolution...

3 weeks ago - Newsfile Corp

New Orleans, Louisiana--(Newsfile Corp. - May 20, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unti...

3 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 20, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) allegi...

3 weeks ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - May 20, 2021) -  Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr....

3 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 20, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emer...

3 weeks ago - Newsfile Corp

BENSALEM, Pa., May 20, 2021 /PRNewswire/ -- Law Offices of Howard G.

3 weeks ago - PRNewsWire

New York, New York--(Newsfile Corp. - May 19, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April...

3 weeks ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 19, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") investors that the firm has filed a...

3 weeks ago - Newsfile Corp

The House Select Subcommittee on the Coronavirus announced last month that they were opening an investigation into Emergent BioSolutions Inc (NYSE: EBS), with two top executives from the company to test...

3 weeks ago - Benzinga

Boston, Massachusetts--(Newsfile Corp. - May 19, 2021) - Block & Leviton LLP announces that a lawsuit for violations of the federal securities laws has been filed against Emergent BioSolutions Inc. (NYS...

3 weeks ago - Newsfile Corp

NEW YORK, May 18, 2021 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24, 2020 thro...

3 weeks ago - PRNewsWire

LOS ANGELES--(BUSINESS WIRE)---- $EBS #EBS--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc.

3 weeks ago - Business Wire

Philadelphia, Pennsylvania--(Newsfile Corp. - May 18, 2021) - Berger Montague announces its investigation into potential securities fraud claims against Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent...

3 weeks ago - Newsfile Corp

About EBS

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Nov 15, 2006
CEO
Robert Kramer
Employees
2,200
Stock Exchange
NYSE
Ticker Symbol
EBS
Full Company Profile

Financial Performance

In 2020, EBS's revenue was $1.56 billion, an increase of 40.63% compared to the previous year's $1.11 billion. Earnings were $305.10 million, an increase of 459.82%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for EBS stock is "Buy." The 12-month stock price forecast is 91.14, which is an increase of 43.50% from the latest price.

Price Target
$91.14
(43.50% upside)
Analyst Consensus: Buy